U.S. Securities and Exchange Commission
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities
and Exchange Act of 1934
NOVEMBER 8, 2012
Date of Report (Date of earliest event Reported)
MESA LABORATORIES, INC.
(Exact Name of Small Business Issuer as Specified in its Charter)
Commission File Number: 0-11740
(State or other Jurisdiction of
Incorporation or Organization)
|12100 WEST SIXTH AVENUE, LAKEWOOD, COLORADO
(Address of Principal Executive Offices)
|| 80228 |
Issuer’s telephone number, including
area code: (303) 987-8000
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
the interim guidance provided in Release No. 33-8216, the disclosure being furnished in this Form 8-K is being furnished under
Item 12, “Results of Operations and Financial Condition,” of form 8-K.
8, 2012, Mesa Laboratories, Inc. issued a press release describing its results of operations for its second quarter ended September
30, 2012. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
||99.1 Press Release issued November 8, 2012|
Pursuant to the requirements of the Securities Exchange Act
of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|MESA LABORATORIES, INC.
|DATED: November 8, 2012
/s/ John J. Sullivan, Ph.D.
||John J. Sullivan, Ph.D.|
Chief Executive Officer,
President and Director
INDEX TO EXHIBITS
Press release dated November 8, 2012
||Method of Filing |